Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced a series of actions as part of its ongoing commitment to strong corporate governance and regular...

Related Keywords

Harvard University , Massachusetts , United States , Boston , Athlone , Westmeath , Ireland , Waltham , Ohio , Cambridge , Cambridgeshire , United Kingdom , Dublin , Alex Denner , Katie Joyce , Emily Peterson Alva , Davida Daglio , Nancyj Wysenski , Catot Laurencin , Christopher Wright , Brianp Mckeon , Wendyl Dixon , Vrije Universiteit , Sandy Coombs , Christopheri Wright , Ironwood Pharmaceuticals Inc , Global Medicines Development , Alkermes , Corporate Governance Committee , Corporate Governance Committee Of The Board , Wendy , Harvard Medical School , Aavantibio Inc , Vertex Pharmaceuticals Incorporated , Axcella Health Inc , Professor Of Neurology At Harvard Medical School , Cyclerion Therapeutics Inc , Biochemical Sciences , Annual Meeting , Chief Medical Officer , Cyclerion Therapeutics , Ironwood Pharmaceuticals , Associate Professor , Harvard Medical , Alkerme Board , Richard Pops , Chief Executive Officer , New Lead Independent Director , Longer Serving Directors , Board Refreshment , Lead Independent Director , Sarissa Capital Management , Chief Investment Officer , Sarissa Capital , Senior Vice President , Chief Development Officer , Axcella Health , Scientific Advisor , Magna Cum Laude , Clinical Investigation , Private Securities Litigation Reform Act , Annual Report , Additional Information , Information Regarding Participants , Current Reports , Initial Statements , Beneficial Ownership , Vertex Pharmaceuticals ,